Campbell David Alan 4
4 · Janux Therapeutics, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Campbell David Alan
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-01-02+81,000→ 298,054 total - Award
Stock option (right to buy)
2025-01-02+283,500→ 283,500 totalExercise: $53.24Exp: 2035-01-01→ Common Stock (283,500 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026.
- [F2]25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.